Lakeshore Biopharma Co.LSBCF
13F holders, Q3 2025 (September 30)1holders −6
0new positions
6sold out
$0.73avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Lakeshore Biopharma Co. Ltd. (LSBCF) in their 13F filings, down 6 from Q2 2025. 0 opened new positions and 6 sold out. The largest holder was Barclays PLC ($18K).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 6 | $305K |
All 13F filers, Q2 2025 → Q3 2025: 298,710 shares sold, net −298,710 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Barclays PLC | 0.00% | No change | 24,757 | $18K |
"% of holder's portfolio" is LSBCF's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.